• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT281212
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code No Code Available (3191)
Date of Event 07/19/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The review of the manufacturing records verified that the lots involved in this event met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), complications associated with the use of the gore® excluder® aaa endoprosthesis may include but are not limited to: endoleaks.
 
Event or Problem Description
The following information was reported to gore: on (b)(6) 2018, this patient underwent emergency endovascular treatment for a ruptured abdominal aortic aneurysm and was treated with gore® excluder® aaa endoprostheses.On (b)(6) 2018, follow-up computed tomography imaging identified a type 1a endoleak resulting from the patient¿s aortic neck length with 10 mm only and therefore considered outside of the instructions for use.On (b)(6) 2018, a re-intervention was performed and it was unsuccessfully attempted to repair the endoleak by using aptus® staples.The situation was subsequently solved by injecting thrombin into the aneurysm sac.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key7815764
Report Number3007284313-2018-00237
Device Sequence Number2336452
Product Code MIH
UDI-Device Identifier00733132622481
UDI-Public00733132622481
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/14/2021
Device Catalogue NumberRLT281212
Device Lot Number17787610
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date08/27/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age76 YR
-
-